Notch1 regulates hepatic thrombopoietin production
| dc.contributor.author | Sun, Yueyue | en |
| dc.contributor.author | Tong, Huan | en |
| dc.contributor.author | Chu, Xiang | en |
| dc.contributor.author | Li, Yingying | en |
| dc.contributor.author | Zhang, Jie | en |
| dc.contributor.author | Ding, Yangyang | en |
| dc.contributor.author | Zhang, Sixuan | en |
| dc.contributor.author | Gui, Xiang | en |
| dc.contributor.author | Chen, Chong | en |
| dc.contributor.author | Xu, Mengdi | en |
| dc.contributor.author | Li, Zhenyu | en |
| dc.contributor.author | Gardiner, Elizabeth E. | en |
| dc.contributor.author | Andrews, Robert K. | en |
| dc.contributor.author | Zeng, Lingyu | en |
| dc.contributor.author | Xu, Kailin | en |
| dc.contributor.author | Qiao, Jianlin | en |
| dc.date.accessioned | 2025-12-17T21:41:11Z | |
| dc.date.available | 2025-12-17T21:41:11Z | |
| dc.date.issued | 2024-04-11 | en |
| dc.description.abstract | Notch signaling regulates cell-fate decisions in several developmental processes and cell functions. However, the role of Notch in hepatic thrombopoietin (TPO) production remains unclear. We noted thrombocytopenia in mice with hepatic Notch1 deficiency and so investigated TPO production and other features of platelets in these mice. We found that the liver ultrastructure and hepatocyte function were comparable between control and Notch1-deficient mice. However, the Notch1-deficient mice had significantly lower plasma TPO and hepatic TPO messenger RNA levels, concomitant with lower numbers of platelets and impaired megakaryocyte differentiation and maturation, which were rescued by addition of exogenous TPO. Additionally, JAK2/STAT3 phosphorylation was significantly inhibited in Notch1-deficient hepatocytes, consistent with the RNA-sequencing analysis. JAK2/STAT3 phosphorylation and TPO production was also impaired in cultured Notch1-deficient hepatocytes after treatment with desialylated platelets. Consistently, hepatocyte-specific Notch1 deletion inhibited JAK2/STAT3 phosphorylation and hepatic TPO production induced by administration of desialylated platelets in vivo. Interestingly, Notch1 deficiency downregulated the expression of HES5 but not HES1. Moreover, desialylated platelets promoted the binding of HES5 to JAK2/STAT3, leading to JAK2/STAT3 phosphorylation and pathway activation in hepatocytes. Hepatocyte Ashwell-Morell receptor (AMR), a heterodimer of asialoglycoprotein receptor 1 [ASGR1] and ASGR2, physically associates with Notch1, and inhibition of AMR impaired Notch1 signaling activation and hepatic TPO production. Furthermore, blockage of Delta-like 4 on desialylated platelets inhibited hepatocyte Notch1 activation and HES5 expression, JAK2/STAT3 phosphorylation, and subsequent TPO production. In conclusion, our study identifies a novel regulatory role of Notch1 in hepatic TPO production, indicating that it might be a target for modulating TPO level. | en |
| dc.description.sponsorship | This work was supported by National Natural Science Foundation of China (grants 82322005, 82261138554, 82170130, 81970124, and 81400082), National Key Research and Development Program of China (grant 2023YFC2507800), the Natural Science Foundation of Jiangsu Province (grant BK20140219), funding for the Distinguished Professorship Program of Jiangsu Province, the Shuangchuang Project of Jiangsu Province, the 333 projects of Jiangsu Province (grant BRA2017542), the Natural Science Foundation of the Jiangsu Higher Education Institutions of China (grant 18KJA320010), Jiangsu Province's Graduate Scientific Research Innovation Program (grants KYCX23-2930, KYCX22-2896, and KYCX21-2691), Youth Science and Technology Innovation Team of Xuzhou Medical University, and the National Health and Medical Research Council of Australia. Contribution: Y.S. H.T. and X.C. performed research, analyzed data, and wrote the manuscript; Y.L. J.Z. Y.D. S.Z. X.G. C.C. M.X. and Z.L. performed research and analyzed data; E.E.G. and R.K.A. provided the intellectual input; L.Z. K.X. and J.Q. conceived and designed the study and wrote the manuscript; and all authors read and revised the manuscript. This work was supported by National Natural Science Foundation of China (grant numbers 82322005 , 82261138554 , 82170130 , 81970124 , and 81400082 ), the Natural Science Foundation of Jiangsu Province (grant number BK20140219 ), the funding for the Distinguished Professorship Program of Jiangsu Province , the Shuangchuang Project of Jiangsu Province , the 333 projects of Jiangsu Province ( BRA2017542 ), the Natural Science Foundation of the Jiangsu Higher Education Institutions of China ( 18KJA320010 ), Jiangsu Province's Graduate Scientific Research Innovation Program ( KYCX23-2930 , KYCX22-2896 , and KYCX21-2691 ), Youth Science and Technology Innovation Team of Xuzhou Medical University , and the National Health and Medical Research Council of Australia. | en |
| dc.description.status | Peer-reviewed | en |
| dc.format.extent | 13 | en |
| dc.identifier.issn | 0006-4971 | en |
| dc.identifier.other | PubMed:38603632 | en |
| dc.identifier.other | WOS:001261949900001 | en |
| dc.identifier.other | ORCID:/0000-0001-9453-9688/work/188017768 | en |
| dc.identifier.scopus | 85192549697 | en |
| dc.identifier.uri | https://hdl.handle.net/1885/733796449 | |
| dc.language.iso | en | en |
| dc.rights | © 2024 The Author(s) | en |
| dc.source | Blood | en |
| dc.subject | Binding | en |
| dc.subject | Signaling pathway | en |
| dc.subject | Liver | en |
| dc.subject | Stat3 | en |
| dc.subject | Mice | en |
| dc.subject | Clearance | en |
| dc.subject | Modifier | en |
| dc.title | Notch1 regulates hepatic thrombopoietin production | en |
| dc.type | Journal article | en |
| dspace.entity.type | Publication | en |
| local.bibliographicCitation.lastpage | 2790 | en |
| local.bibliographicCitation.startpage | 2778 | en |
| local.contributor.affiliation | Sun, Yueyue; Xuzhou Medical University | en |
| local.contributor.affiliation | Tong, Huan; Xuzhou Medical University | en |
| local.contributor.affiliation | Chu, Xiang; Xuzhou Medical University | en |
| local.contributor.affiliation | Li, Yingying; Xuzhou Medical University | en |
| local.contributor.affiliation | Zhang, Jie; Xuzhou Medical University | en |
| local.contributor.affiliation | Ding, Yangyang; Xuzhou Medical University | en |
| local.contributor.affiliation | Zhang, Sixuan; Xuzhou Medical University | en |
| local.contributor.affiliation | Gui, Xiang; Xuzhou Medical University | en |
| local.contributor.affiliation | Chen, Chong; Xuzhou Medical University | en |
| local.contributor.affiliation | Xu, Mengdi; Xuzhou Medical University | en |
| local.contributor.affiliation | Li, Zhenyu; Xuzhou Medical University | en |
| local.contributor.affiliation | Gardiner, Elizabeth E.; Genome Sciences, Genome Sciences and Cancer Division, John Curtin School of Medical Research, ANU College of Science and Medicine, The Australian National University | en |
| local.contributor.affiliation | Andrews, Robert K.; John Curtin School of Medical Research, ANU College of Science and Medicine, The Australian National University | en |
| local.contributor.affiliation | Zeng, Lingyu; Xuzhou Medical University | en |
| local.contributor.affiliation | Xu, Kailin; Xuzhou Medical University | en |
| local.contributor.affiliation | Qiao, Jianlin; Xuzhou Medical University | en |
| local.identifier.citationvolume | 143 | en |
| local.identifier.doi | 10.1182/blood.2023023559 | en |
| local.identifier.pure | cb7faf1c-09cc-4d62-b353-64735af720be | en |
| local.identifier.url | https://www.scopus.com/pages/publications/85192549697 | en |
| local.type.status | Published | en |